Your browser doesn't support javascript.
loading
The clinical- and cost-effectiveness of functional electrical stimulation and ankle-foot orthoses for foot drop in Multiple Sclerosis: a multicentre randomized trial.
Renfrew, Linda Miller; Paul, Lorna; McFadyen, Angus; Rafferty, Danny; Moseley, Owen; Lord, Anna C; Bowers, Roy; Mattison, Paul.
Affiliation
  • Renfrew LM; 1 Douglas Grant Rehabilitation Centre, Ayrshire Central Hospital, NHS Ayrshire & Arran, Irvine, UK.
  • Paul L; 2 School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, UK.
  • McFadyen A; 3 AKM Statistics, Glasgow, UK.
  • Rafferty D; 2 School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, UK.
  • Moseley O; 4 Independent Consultant, Ayrshire, UK.
  • Lord AC; 1 Douglas Grant Rehabilitation Centre, Ayrshire Central Hospital, NHS Ayrshire & Arran, Irvine, UK.
  • Bowers R; 5 Department of Biomedical Engineering, University of Strathclyde, Glasgow, UK.
  • Mattison P; 1 Douglas Grant Rehabilitation Centre, Ayrshire Central Hospital, NHS Ayrshire & Arran, Irvine, UK.
Clin Rehabil ; 33(7): 1150-1162, 2019 Jul.
Article in En | MEDLINE | ID: mdl-30974955
ABSTRACT

OBJECTIVE:

To compare the clinical- and cost-effectiveness of ankle-foot orthoses (AFOs) and functional electrical stimulation (FES) over 12 months in people with Multiple Sclerosis with foot drop.

DESIGN:

Multicentre, powered, non-blinded, randomized trial.

SETTING:

Seven Multiple Sclerosis outpatient centres across Scotland.

SUBJECTS:

Eighty-five treatment-naïve people with Multiple Sclerosis with persistent (>three months) foot drop.

INTERVENTIONS:

Participants randomized to receive a custom-made, AFO (n = 43) or FES device (n = 42). OUTCOME

MEASURES:

Assessed at 0, 3, 6 and 12 months; 5-minute self-selected walk test (primary), Timed 25 Foot Walk, oxygen cost of walking, Multiple Sclerosis Impact Scale-29, Multiple Sclerosis Walking Scale-12, Modified Fatigue Impact Scale, Euroqol five-dimension five-level questionnaire, Activities-specific Balance and Confidence Scale, Psychological Impact of Assistive Devices Score, and equipment and National Health Service staff time costs of interventions.

RESULTS:

Groups were similar for age (AFO, 51.4 (11.2); FES, 50.4(10.4) years) and baseline walking speed (AFO, 0.62 (0.21); FES 0.73 (0.27) m/s). In all, 38% dropped out by 12 months (AFO, n = 21; FES, n = 11). Both groups walked faster at 12 months with device (P < 0.001; AFO, 0.73 (0.24); FES, 0.79 (0.24) m/s) but no difference between groups. Significantly higher Psychological Impact of Assistive Devices Scores were found for FES for Competence (P = 0.016; AFO, 0.85(1.05); FES, 1.53(1.05)), Adaptability (P = 0.001; AFO, 0.38(0.97); FES 1.53 (0.98)) and Self-Esteem (P = 0.006; AFO, 0.45 (0.67); FES 1 (0.68)). Effects were comparable for other measures. FES may offer value for money alternative to usual care.

CONCLUSION:

AFOs and FES have comparable effects on walking performance and patient-reported outcomes; however, high drop-outs introduces uncertainty.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Electric Stimulation Therapy / Peroneal Neuropathies / Foot Orthoses / Multiple Sclerosis Type of study: Clinical_trials / Etiology_studies / Health_economic_evaluation Aspects: Patient_preference Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Clin Rehabil Journal subject: REABILITACAO Year: 2019 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Electric Stimulation Therapy / Peroneal Neuropathies / Foot Orthoses / Multiple Sclerosis Type of study: Clinical_trials / Etiology_studies / Health_economic_evaluation Aspects: Patient_preference Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Clin Rehabil Journal subject: REABILITACAO Year: 2019 Document type: Article Affiliation country: